VEGFA and neoplasm: These changes appear to be correlated with the presence of subretinal fluid and larger tumor size, bringing to light the possible role of tumor-related pro-inflammatory factors, such as vascular endothelial growth factor (VEGF), in the pathogenesis of vision loss in CM9.